Annual EBITDA
-$52.18 M
-$7.47 M-16.71%
December 31, 2023
Summary
- As of February 9, 2025, LIFE annual EBITDA is -$52.18 million, with the most recent change of -$7.47 million (-16.71%) on December 31, 2023.
- During the last 3 years, LIFE annual EBITDA has fallen by -$37.53 million (-256.29%).
Performance
LIFE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$15.87 M
-$314.00 K-2.02%
March 31, 2024
Summary
- As of February 9, 2025, LIFE quarterly EBITDA is -$15.87 million, with the most recent change of -$314.00 thousand (-2.02%) on March 31, 2024.
- Over the past year, LIFE quarterly EBITDA has dropped by -$3.83 million (-31.87%).
Performance
LIFE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$56.01 M
-$3.83 M-7.35%
March 31, 2024
Summary
- As of February 9, 2025, LIFE TTM EBITDA is -$56.01 million, with the most recent change of -$3.83 million (-7.35%) on March 31, 2024.
- Over the past year, LIFE TTM EBITDA has dropped by -$11.35 million (-25.42%).
Performance
LIFE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LIFE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.7% | -31.9% | -25.4% |
| 3 y3 years | -256.3% | -29.0% | -39.7% |
| 5 y5 years | -62.7% | -186.3% | -159.2% |
LIFE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +59.5% | at low | +118.8% | at low | +71.2% | at low |
| 5 y | 5-year | +256.3% | at low | -815.7% | at low | +304.3% | at low |
| alltime | all time | +256.3% | +9.3% | -815.7% | +2.5% | +878.0% | +8.9% |
ATyr Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$15.87 M(+2.0%) | -$56.01 M(+7.3%) |
| Dec 2023 | -$52.18 M(+16.7%) | -$15.55 M(+33.8%) | -$52.18 M(+18.9%) |
| Sep 2023 | - | -$11.62 M(-10.4%) | -$43.88 M(-3.2%) |
| Jun 2023 | - | -$12.97 M(+7.8%) | -$45.34 M(+1.5%) |
| Mar 2023 | - | -$12.03 M(+65.9%) | -$44.66 M(-0.1%) |
| Dec 2022 | -$44.71 M(+36.7%) | -$7.25 M(-44.5%) | -$44.71 M(-2.3%) |
| Sep 2022 | - | -$13.08 M(+6.3%) | -$45.78 M(+14.2%) |
| Jun 2022 | - | -$12.30 M(+1.8%) | -$40.10 M(+5.8%) |
| Mar 2022 | - | -$12.08 M(+45.2%) | -$37.89 M(+15.8%) |
| Dec 2021 | -$32.71 M(+123.4%) | -$8.32 M(+12.4%) | -$32.71 M(+12.5%) |
| Sep 2021 | - | -$7.40 M(-26.6%) | -$29.09 M(+4.3%) |
| Jun 2021 | - | -$10.09 M(+46.1%) | -$27.90 M(+17.4%) |
| Mar 2021 | - | -$6.91 M(+47.1%) | -$23.77 M(+62.3%) |
| Dec 2020 | -$14.64 M(-32.2%) | -$4.69 M(-24.4%) | -$14.64 M(-5.9%) |
| Sep 2020 | - | -$6.21 M(+4.3%) | -$15.56 M(+7.3%) |
| Jun 2020 | - | -$5.96 M(-368.7%) | -$14.51 M(+4.7%) |
| Mar 2020 | - | $2.22 M(-139.5%) | -$13.85 M(-35.9%) |
| Dec 2019 | -$21.61 M(-32.6%) | -$5.61 M(+8.8%) | -$21.61 M(-0.8%) |
| Sep 2019 | - | -$5.16 M(-2.8%) | -$21.79 M(-5.7%) |
| Jun 2019 | - | -$5.30 M(-4.3%) | -$23.11 M(-16.2%) |
| Mar 2019 | - | -$5.54 M(-4.2%) | -$27.58 M(-14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$32.07 M(-30.9%) | -$5.78 M(-10.8%) | -$32.07 M(-14.1%) |
| Sep 2018 | - | -$6.49 M(-33.6%) | -$37.33 M(-10.1%) |
| Jun 2018 | - | -$9.77 M(-2.7%) | -$41.52 M(-4.5%) |
| Mar 2018 | - | -$10.04 M(-9.1%) | -$43.48 M(-6.4%) |
| Dec 2017 | -$46.43 M(-18.6%) | -$11.04 M(+3.4%) | -$46.43 M(-2.7%) |
| Sep 2017 | - | -$10.68 M(-9.0%) | -$47.70 M(-5.9%) |
| Jun 2017 | - | -$11.73 M(-9.6%) | -$50.67 M(-6.4%) |
| Mar 2017 | - | -$12.98 M(+5.5%) | -$54.14 M(-5.1%) |
| Dec 2016 | -$57.04 M(+22.0%) | -$12.31 M(-9.8%) | -$57.04 M(-6.5%) |
| Sep 2016 | - | -$13.64 M(-10.3%) | -$60.99 M(+4.4%) |
| Jun 2016 | - | -$15.21 M(-4.2%) | -$58.44 M(+8.4%) |
| Mar 2016 | - | -$15.88 M(-2.3%) | -$53.92 M(+15.3%) |
| Dec 2015 | -$46.75 M(+105.7%) | -$16.26 M(+46.6%) | -$46.75 M(+28.7%) |
| Sep 2015 | - | -$11.09 M(+3.8%) | -$36.31 M(+16.2%) |
| Jun 2015 | - | -$10.69 M(+22.7%) | -$31.24 M(+21.5%) |
| Mar 2015 | - | -$8.71 M(+49.7%) | -$25.71 M(+13.1%) |
| Dec 2014 | -$22.73 M(+20.7%) | -$5.82 M(-3.3%) | -$22.73 M(+34.4%) |
| Sep 2014 | - | -$6.02 M(+16.8%) | -$16.90 M(+55.3%) |
| Jun 2014 | - | -$5.16 M(-10.0%) | -$10.88 M(+90.0%) |
| Mar 2014 | - | -$5.73 M | -$5.73 M |
| Dec 2013 | -$18.83 M | - | - |
FAQ
- What is aTyr Pharma annual EBITDA?
- What is the all time high annual EBITDA for aTyr Pharma?
- What is aTyr Pharma annual EBITDA year-on-year change?
- What is aTyr Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for aTyr Pharma?
- What is aTyr Pharma quarterly EBITDA year-on-year change?
- What is aTyr Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for aTyr Pharma?
- What is aTyr Pharma TTM EBITDA year-on-year change?
What is aTyr Pharma annual EBITDA?
The current annual EBITDA of LIFE is -$52.18 M
What is the all time high annual EBITDA for aTyr Pharma?
aTyr Pharma all-time high annual EBITDA is -$14.64 M
What is aTyr Pharma annual EBITDA year-on-year change?
Over the past year, LIFE annual EBITDA has changed by -$7.47 M (-16.71%)
What is aTyr Pharma quarterly EBITDA?
The current quarterly EBITDA of LIFE is -$15.87 M
What is the all time high quarterly EBITDA for aTyr Pharma?
aTyr Pharma all-time high quarterly EBITDA is $2.22 M
What is aTyr Pharma quarterly EBITDA year-on-year change?
Over the past year, LIFE quarterly EBITDA has changed by -$3.83 M (-31.87%)
What is aTyr Pharma TTM EBITDA?
The current TTM EBITDA of LIFE is -$56.01 M
What is the all time high TTM EBITDA for aTyr Pharma?
aTyr Pharma all-time high TTM EBITDA is -$5.73 M
What is aTyr Pharma TTM EBITDA year-on-year change?
Over the past year, LIFE TTM EBITDA has changed by -$11.35 M (-25.42%)